Algamed Therapeutics
Bioactive Platform for Treatment of Vaginal Dryness
Company Overview
Snapshot
Founded in August 2014, Algamed Therapeutics operates with 1–10 employees. The company has raised $910,000 across two funding rounds from a single investor. In September 2021, Algamed Therapeutics secured equity crowdfunding from PipelBiz.
Business overview
Algamed Therapeutics is a Health Tech & Life Sciences company specializing in developing technologies for common vaginal conditions, including dryness, infections, and dyspareunia. Its core product, Secret de Joie, is a natural, hormone-free jelly designed to treat vaginal dryness, particularly for breast and ovarian cancer survivors, postmenopausal women, and those with diabetes or on birth control. The company operates in the Pharmaceuticals sector, serving consumers and distributors in the United States and Canada.
Strategic signal
In November 2021, Algamed Therapeutics was highlighted for its innovative approach to femtech solutions, leveraging natural ingredients to address women's health issues. This signals a growing investor interest in specialized, natural-based treatments within the women's health market, positioning Algamed Therapeutics as a key player in developing non-hormonal alternatives for prevalent conditions.
Log in to access full profile ›Company Intelligence Q&A
- What is Algamed Therapeutics' primary product?
- Algamed Therapeutics' primary product is Secret de Joie, a natural, hormone-free jelly developed to treat vaginal dryness.
- When was Algamed Therapeutics founded?
- Algamed Therapeutics was founded in August 2014.
- What was a significant funding event for Algamed Therapeutics?
- In September 2021, Algamed Therapeutics secured equity crowdfunding from PipelBiz.
- What market does Algamed Therapeutics primarily target?
- Algamed Therapeutics primarily targets women experiencing vaginal dryness, including breast and ovarian cancer survivors, postmenopausal women, and those with diabetes, in markets such as the United States and Canada.
- What is the total capital raised by Algamed Therapeutics?
- Algamed Therapeutics has raised a total of $910,000 across two funding rounds.